nodes	percent_of_prediction	percent_of_DWPC	metapath
Carmustine—CYP1A2—Carbamazepine—epilepsy syndrome	0.0801	0.203	CbGbCtD
Carmustine—CYP1A2—Primidone—epilepsy syndrome	0.0747	0.19	CbGbCtD
Carmustine—CYP1A2—Propofol—epilepsy syndrome	0.067	0.17	CbGbCtD
Carmustine—CYP1A2—Phenobarbital—epilepsy syndrome	0.064	0.162	CbGbCtD
Carmustine—CYP1A2—Diazepam—epilepsy syndrome	0.0607	0.154	CbGbCtD
Carmustine—CYP1A2—Valproic Acid—epilepsy syndrome	0.0478	0.121	CbGbCtD
Carmustine—GSR—Synthesis and interconversion of nucleotide di- and triphosphates—TXNRD1—epilepsy syndrome	0.007	0.0566	CbGpPWpGaD
Carmustine—GSR—hindbrain—epilepsy syndrome	0.00669	0.209	CbGeAlD
Carmustine—GSR—Selenium Micronutrient Network—SEPW1—epilepsy syndrome	0.00549	0.0443	CbGpPWpGaD
Carmustine—GSR—Detoxification of Reactive Oxygen Species—TXNRD1—epilepsy syndrome	0.00506	0.0409	CbGpPWpGaD
Carmustine—GSR—Oxidative Stress—TXNRD1—epilepsy syndrome	0.00465	0.0376	CbGpPWpGaD
Carmustine—GSR—Nucleotide metabolism—ADK—epilepsy syndrome	0.00458	0.037	CbGpPWpGaD
Carmustine—GSR—brainstem—epilepsy syndrome	0.00383	0.12	CbGeAlD
Carmustine—GSR—Selenium Micronutrient Network—PNPO—epilepsy syndrome	0.0038	0.0307	CbGpPWpGaD
Carmustine—GSR—forebrain—epilepsy syndrome	0.0037	0.116	CbGeAlD
Carmustine—GSR—Oxidative Stress—MAPK10—epilepsy syndrome	0.00367	0.0297	CbGpPWpGaD
Carmustine—Lomustine—CYP2D6—epilepsy syndrome	0.00352	1	CrCbGaD
Carmustine—GSR—telencephalon—epilepsy syndrome	0.0034	0.107	CbGeAlD
Carmustine—GSR—Nucleotide metabolism—ATIC—epilepsy syndrome	0.00317	0.0256	CbGpPWpGaD
Carmustine—GSR—Nucleotide metabolism—UPB1—epilepsy syndrome	0.00317	0.0256	CbGpPWpGaD
Carmustine—GSR—Nucleotide metabolism—NT5E—epilepsy syndrome	0.00263	0.0212	CbGpPWpGaD
Carmustine—GSR—Oxidative Stress—JUNB—epilepsy syndrome	0.00261	0.0211	CbGpPWpGaD
Carmustine—GSR—midbrain—epilepsy syndrome	0.00244	0.0765	CbGeAlD
Carmustine—GSR—Nucleotide metabolism—ADSL—epilepsy syndrome	0.00241	0.0194	CbGpPWpGaD
Carmustine—GSR—Metapathway biotransformation—KCNAB2—epilepsy syndrome	0.0024	0.0194	CbGpPWpGaD
Carmustine—GSR—Glutathione metabolism—GPX1—epilepsy syndrome	0.00239	0.0193	CbGpPWpGaD
Carmustine—GSR—spinal cord—epilepsy syndrome	0.00238	0.0746	CbGeAlD
Carmustine—GSR—Detoxification of Reactive Oxygen Species—CAT—epilepsy syndrome	0.00232	0.0188	CbGpPWpGaD
Carmustine—GSR—Nucleotide metabolism—TXNRD1—epilepsy syndrome	0.00217	0.0175	CbGpPWpGaD
Carmustine—GSR—Oxidative Stress—HMOX1—epilepsy syndrome	0.00216	0.0175	CbGpPWpGaD
Carmustine—GSR—Oxidative Stress—CAT—epilepsy syndrome	0.00214	0.0173	CbGpPWpGaD
Carmustine—GSR—head—epilepsy syndrome	0.00212	0.0663	CbGeAlD
Carmustine—GSR—NRF2 pathway—SLC6A8—epilepsy syndrome	0.0021	0.017	CbGpPWpGaD
Carmustine—GSR—Detoxification of Reactive Oxygen Species—GPX1—epilepsy syndrome	0.0021	0.017	CbGpPWpGaD
Carmustine—GSR—nervous system—epilepsy syndrome	0.00201	0.0629	CbGeAlD
Carmustine—GSR—Selenium Micronutrient Network—TXNRD1—epilepsy syndrome	0.00197	0.0159	CbGpPWpGaD
Carmustine—GSR—central nervous system—epilepsy syndrome	0.00193	0.0605	CbGeAlD
Carmustine—GSR—Oxidative Stress—GPX1—epilepsy syndrome	0.00193	0.0156	CbGpPWpGaD
Carmustine—GSR—cerebellum—epilepsy syndrome	0.00189	0.0592	CbGeAlD
Carmustine—GSR—brain—epilepsy syndrome	0.00153	0.0481	CbGeAlD
Carmustine—GSR—Oxidative Stress—FOS—epilepsy syndrome	0.00143	0.0115	CbGpPWpGaD
Carmustine—GSR—NRF2 pathway—TXNRD1—epilepsy syndrome	0.00131	0.0106	CbGpPWpGaD
Carmustine—GSR—Selenium Micronutrient Network—PLAT—epilepsy syndrome	0.00117	0.00942	CbGpPWpGaD
Carmustine—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C19—epilepsy syndrome	0.00115	0.00929	CbGpPWpGaD
Carmustine—GSR—NRF2 pathway—ABCC2—epilepsy syndrome	0.0011	0.00892	CbGpPWpGaD
Carmustine—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C19—epilepsy syndrome	0.00105	0.00845	CbGpPWpGaD
Carmustine—GSR—NRF2 pathway—SLC6A1—epilepsy syndrome	0.00103	0.00829	CbGpPWpGaD
Carmustine—GSR—Nucleotide metabolism—CAT—epilepsy syndrome	0.000995	0.00803	CbGpPWpGaD
Carmustine—GSR—Selenium Micronutrient Network—CAT—epilepsy syndrome	0.000903	0.0073	CbGpPWpGaD
Carmustine—GSR—Nucleotide metabolism—GPX1—epilepsy syndrome	0.000899	0.00727	CbGpPWpGaD
Carmustine—CYP1A2—Tryptophan metabolism—WARS—epilepsy syndrome	0.00086	0.00695	CbGpPWpGaD
Carmustine—GSR—NRF2 pathway—SLC6A4—epilepsy syndrome	0.000821	0.00663	CbGpPWpGaD
Carmustine—GSR—Selenium Micronutrient Network—GPX1—epilepsy syndrome	0.000817	0.0066	CbGpPWpGaD
Carmustine—GSR—Cellular responses to stress—TXNRD1—epilepsy syndrome	0.000817	0.0066	CbGpPWpGaD
Carmustine—GSR—Metapathway biotransformation—CYP2C19—epilepsy syndrome	0.000791	0.00639	CbGpPWpGaD
Carmustine—GSR—Metapathway biotransformation—CYP11A1—epilepsy syndrome	0.000787	0.00635	CbGpPWpGaD
Carmustine—GSR—NRF2 pathway—SLC2A1—epilepsy syndrome	0.000742	0.006	CbGpPWpGaD
Carmustine—GSR—Selenium Micronutrient Network—CRP—epilepsy syndrome	0.000717	0.00579	CbGpPWpGaD
Carmustine—CYP1A2—Melatonin metabolism and effects—MAP2—epilepsy syndrome	0.000714	0.00577	CbGpPWpGaD
Carmustine—GSR—Metapathway biotransformation—CYP2D6—epilepsy syndrome	0.00071	0.00573	CbGpPWpGaD
Carmustine—GSR—NRF2 pathway—HBEGF—epilepsy syndrome	0.000698	0.00564	CbGpPWpGaD
Carmustine—GSR—Cellular responses to stress—MAPK10—epilepsy syndrome	0.000644	0.00521	CbGpPWpGaD
Carmustine—GSR—NRF2 pathway—HMOX1—epilepsy syndrome	0.00061	0.00493	CbGpPWpGaD
Carmustine—CYP1A2—Fatty Acid Omega Oxidation—CYP2D6—epilepsy syndrome	0.000592	0.00478	CbGpPWpGaD
Carmustine—GSR—Selenium Micronutrient Network—CCL2—epilepsy syndrome	0.00059	0.00476	CbGpPWpGaD
Carmustine—CYP1A2—Xenobiotics—CYP2C19—epilepsy syndrome	0.000552	0.00446	CbGpPWpGaD
Carmustine—GSR—Selenium Micronutrient Network—ALB—epilepsy syndrome	0.00055	0.00444	CbGpPWpGaD
Carmustine—GSR—Metabolism—CA13—epilepsy syndrome	0.000549	0.00443	CbGpPWpGaD
Carmustine—CYP1A2—Tamoxifen metabolism—CYP2C19—epilepsy syndrome	0.000531	0.00429	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—RET—epilepsy syndrome	0.000507	0.00409	CbGpPWpGaD
Carmustine—GSR—Cellular responses to stress—EPO—epilepsy syndrome	0.000501	0.00405	CbGpPWpGaD
Carmustine—CYP1A2—Xenobiotics—CYP2D6—epilepsy syndrome	0.000495	0.004	CbGpPWpGaD
Carmustine—GSR—Selenium Micronutrient Network—RELA—epilepsy syndrome	0.000495	0.004	CbGpPWpGaD
Carmustine—GSR—Selenium Micronutrient Network—PTGS2—epilepsy syndrome	0.000481	0.00388	CbGpPWpGaD
Carmustine—CYP1A2—Tamoxifen metabolism—CYP2D6—epilepsy syndrome	0.000476	0.00385	CbGpPWpGaD
Carmustine—GSR—Selenium Micronutrient Network—IL1B—epilepsy syndrome	0.000447	0.00361	CbGpPWpGaD
Carmustine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC2—epilepsy syndrome	0.000436	0.00352	CbGpPWpGaD
Carmustine—GSR—Metabolism—CERS1—epilepsy syndrome	0.000416	0.00336	CbGpPWpGaD
Carmustine—GSR—Metabolism—ADK—epilepsy syndrome	0.000416	0.00336	CbGpPWpGaD
Carmustine—GSR—Metabolism—FAR1—epilepsy syndrome	0.000416	0.00336	CbGpPWpGaD
Carmustine—GSR—Metabolism—PDXK—epilepsy syndrome	0.000416	0.00336	CbGpPWpGaD
Carmustine—GSR—Metabolism—L2HGDH—epilepsy syndrome	0.000416	0.00336	CbGpPWpGaD
Carmustine—GSR—Metabolism—GLUD1—epilepsy syndrome	0.000416	0.00336	CbGpPWpGaD
Carmustine—CYP1A2—Melatonin metabolism and effects—CYP2C19—epilepsy syndrome	0.00041	0.00331	CbGpPWpGaD
Carmustine—CYP1A2—Tryptophan metabolism—UBE3A—epilepsy syndrome	0.000401	0.00324	CbGpPWpGaD
Carmustine—GSR—Metabolism—PNPO—epilepsy syndrome	0.00038	0.00307	CbGpPWpGaD
Carmustine—GSR—Metabolism—EPM2A—epilepsy syndrome	0.00038	0.00307	CbGpPWpGaD
Carmustine—GSR—Metabolism—NHLRC1—epilepsy syndrome	0.00038	0.00307	CbGpPWpGaD
Carmustine—GSR—Metabolism—GAMT—epilepsy syndrome	0.00038	0.00307	CbGpPWpGaD
Carmustine—GSR—Cellular responses to stress—CAT—epilepsy syndrome	0.000375	0.00303	CbGpPWpGaD
Carmustine—GSR—Cellular responses to stress—SIRT1—epilepsy syndrome	0.000369	0.00298	CbGpPWpGaD
Carmustine—CYP1A2—Melatonin metabolism and effects—CYP2D6—epilepsy syndrome	0.000368	0.00297	CbGpPWpGaD
Carmustine—GSR—Metabolism—CA4—epilepsy syndrome	0.000354	0.00286	CbGpPWpGaD
Carmustine—GSR—Metabolism—QDPR—epilepsy syndrome	0.000354	0.00286	CbGpPWpGaD
Carmustine—GSR—Cellular responses to stress—H2AFX—epilepsy syndrome	0.000345	0.00279	CbGpPWpGaD
Carmustine—GSR—Cellular responses to stress—GPX1—epilepsy syndrome	0.000339	0.00274	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUND—epilepsy syndrome	0.000336	0.00271	CbGpPWpGaD
Carmustine—GSR—Metabolism—COX3—epilepsy syndrome	0.000333	0.00269	CbGpPWpGaD
Carmustine—GSR—Selenium Micronutrient Network—TNF—epilepsy syndrome	0.000325	0.00262	CbGpPWpGaD
Carmustine—GSR—Metabolism—KCNB1—epilepsy syndrome	0.000315	0.00255	CbGpPWpGaD
Carmustine—GSR—Metabolism—SLCO1A2—epilepsy syndrome	0.000315	0.00255	CbGpPWpGaD
Carmustine—GSR—Metabolism—CACNA2D2—epilepsy syndrome	0.000315	0.00255	CbGpPWpGaD
Carmustine—GSR—Metabolism—SLC6A8—epilepsy syndrome	0.000315	0.00255	CbGpPWpGaD
Carmustine—GSR—Metabolism—PFKL—epilepsy syndrome	0.000315	0.00255	CbGpPWpGaD
Carmustine—CYP1A2—Metapathway biotransformation—KCNAB2—epilepsy syndrome	0.000295	0.00239	CbGpPWpGaD
Carmustine—GSR—Metabolism—UPB1—epilepsy syndrome	0.000288	0.00233	CbGpPWpGaD
Carmustine—GSR—Metabolism—ATIC—epilepsy syndrome	0.000288	0.00233	CbGpPWpGaD
Carmustine—GSR—Metabolism—NEU1—epilepsy syndrome	0.000288	0.00233	CbGpPWpGaD
Carmustine—GSR—Cellular responses to stress—ATM—epilepsy syndrome	0.000281	0.00227	CbGpPWpGaD
Carmustine—GSR—Metabolism—HSD17B4—epilepsy syndrome	0.000278	0.00224	CbGpPWpGaD
Carmustine—GSR—Metabolism—GBE1—epilepsy syndrome	0.000268	0.00217	CbGpPWpGaD
Carmustine—GSR—Metabolism—PPP1R3C—epilepsy syndrome	0.000268	0.00217	CbGpPWpGaD
Carmustine—CYP1A2—Arachidonic acid metabolism—CYP2C19—epilepsy syndrome	0.000265	0.00214	CbGpPWpGaD
Carmustine—GSR—Metabolism—ASAH1—epilepsy syndrome	0.000252	0.00204	CbGpPWpGaD
Carmustine—GSR—Cellular responses to stress—FOS—epilepsy syndrome	0.000251	0.00203	CbGpPWpGaD
Carmustine—CYP1A2—Estrogen Receptor Pathway—JUN—epilepsy syndrome	0.000246	0.00199	CbGpPWpGaD
Carmustine—GSR—Metabolism—STXBP1—epilepsy syndrome	0.000245	0.00198	CbGpPWpGaD
Carmustine—GSR—Metabolism—NT5E—epilepsy syndrome	0.000239	0.00193	CbGpPWpGaD
Carmustine—GSR—Metabolism—ALAD—epilepsy syndrome	0.000239	0.00193	CbGpPWpGaD
Carmustine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—epilepsy syndrome	0.000231	0.00187	CbGpPWpGaD
Carmustine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—epilepsy syndrome	0.000231	0.00187	CbGpPWpGaD
Carmustine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2C19—epilepsy syndrome	0.000229	0.00185	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUNB—epilepsy syndrome	0.000228	0.00185	CbGpPWpGaD
Carmustine—GSR—Metabolism—ALDH7A1—epilepsy syndrome	0.000228	0.00184	CbGpPWpGaD
Carmustine—GSR—Metabolism—CACNA1A—epilepsy syndrome	0.000228	0.00184	CbGpPWpGaD
Carmustine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP11A1—epilepsy syndrome	0.000228	0.00184	CbGpPWpGaD
Carmustine—CYP1A2—Oxidation by Cytochrome P450—CYP2C19—epilepsy syndrome	0.000226	0.00183	CbGpPWpGaD
Carmustine—CYP1A2—Oxidation by Cytochrome P450—CYP11A1—epilepsy syndrome	0.000225	0.00182	CbGpPWpGaD
Carmustine—GSR—Metabolism—ST3GAL3—epilepsy syndrome	0.000223	0.0018	CbGpPWpGaD
Carmustine—GSR—Metabolism—ADSL—epilepsy syndrome	0.000219	0.00177	CbGpPWpGaD
Carmustine—GSR—Metabolism—GLUL—epilepsy syndrome	0.000214	0.00173	CbGpPWpGaD
Carmustine—GSR—Metabolism—CACNA1D—epilepsy syndrome	0.00021	0.0017	CbGpPWpGaD
Carmustine—CYP1A2—Melatonin metabolism and effects—APOE—epilepsy syndrome	0.00021	0.0017	CbGpPWpGaD
Carmustine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2D6—epilepsy syndrome	0.000206	0.00166	CbGpPWpGaD
Carmustine—GSR—Cellular responses to stress—RELA—epilepsy syndrome	0.000205	0.00166	CbGpPWpGaD
Carmustine—CYP1A2—Oxidation by Cytochrome P450—CYP2D6—epilepsy syndrome	0.000203	0.00164	CbGpPWpGaD
Carmustine—GSR—Cellular responses to stress—MTOR—epilepsy syndrome	0.000201	0.00163	CbGpPWpGaD
Carmustine—GSR—Metabolism—TXNRD1—epilepsy syndrome	0.000197	0.00159	CbGpPWpGaD
Carmustine—GSR—Metabolism—AQP1—epilepsy syndrome	0.000191	0.00154	CbGpPWpGaD
Carmustine—CYP1A2—Tryptophan metabolism—CAT—epilepsy syndrome	0.000187	0.00151	CbGpPWpGaD
Carmustine—CYP1A2—Phase 1 - Functionalization of compounds—CYP2C19—epilepsy syndrome	0.000186	0.0015	CbGpPWpGaD
Carmustine—CYP1A2—Phase 1 - Functionalization of compounds—CYP11A1—epilepsy syndrome	0.000185	0.00149	CbGpPWpGaD
Carmustine—GSR—Cellular responses to stress—JUN—epilepsy syndrome	0.00018	0.00145	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—HES1—epilepsy syndrome	0.000177	0.00143	CbGpPWpGaD
Carmustine—GSR—Metabolism—CHRM3—epilepsy syndrome	0.000173	0.0014	CbGpPWpGaD
Carmustine—GSR—Metabolism—KCNJ11—epilepsy syndrome	0.000173	0.0014	CbGpPWpGaD
Carmustine—CYP1A2—Phase 1 - Functionalization of compounds—CYP2D6—epilepsy syndrome	0.000167	0.00135	CbGpPWpGaD
Carmustine—CYP1A2—Arachidonic acid metabolism—GPX1—epilepsy syndrome	0.000158	0.00128	CbGpPWpGaD
Carmustine—GSR—Cellular responses to stress—VEGFA—epilepsy syndrome	0.000157	0.00127	CbGpPWpGaD
Carmustine—GSR—Metabolism—ABCG2—epilepsy syndrome	0.000141	0.00114	CbGpPWpGaD
Carmustine—GSR—Metabolism—CYP2C19—epilepsy syndrome	0.000137	0.00111	CbGpPWpGaD
Carmustine—GSR—Metabolism—CYP11A1—epilepsy syndrome	0.000136	0.0011	CbGpPWpGaD
Carmustine—GSR—Metabolism—CYP2D6—epilepsy syndrome	0.000123	0.000994	CbGpPWpGaD
Carmustine—GSR—Metabolism—ADRA2A—epilepsy syndrome	0.000117	0.000947	CbGpPWpGaD
Carmustine—GSR—Metabolism—BCHE—epilepsy syndrome	0.000117	0.000943	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—CERS1—epilepsy syndrome	0.000115	0.000929	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—FAR1—epilepsy syndrome	0.000115	0.000929	CbGpPWpGaD
Carmustine—Abdominal pain—Carbamazepine—epilepsy syndrome	0.000113	0.000253	CcSEcCtD
Carmustine—Diarrhoea—Diazepam—epilepsy syndrome	0.000113	0.000253	CcSEcCtD
Carmustine—Gastrointestinal pain—Lamotrigine—epilepsy syndrome	0.000113	0.000253	CcSEcCtD
Carmustine—Rash—Levetiracetam—epilepsy syndrome	0.000112	0.000251	CcSEcCtD
Carmustine—Anaemia—Pregabalin—epilepsy syndrome	0.000112	0.000251	CcSEcCtD
Carmustine—Dermatitis—Levetiracetam—epilepsy syndrome	0.000112	0.000251	CcSEcCtD
Carmustine—Asthenia—Zonisamide—epilepsy syndrome	0.000112	0.000251	CcSEcCtD
Carmustine—Mental disorder—Gabapentin—epilepsy syndrome	0.000112	0.000251	CcSEcCtD
Carmustine—Agitation—Pregabalin—epilepsy syndrome	0.000112	0.00025	CcSEcCtD
Carmustine—Headache—Levetiracetam—epilepsy syndrome	0.000112	0.00025	CcSEcCtD
Carmustine—Erythema—Gabapentin—epilepsy syndrome	0.000111	0.000249	CcSEcCtD
Carmustine—Malnutrition—Gabapentin—epilepsy syndrome	0.000111	0.000249	CcSEcCtD
Carmustine—GSR—Metabolism—SLC2A1—epilepsy syndrome	0.000111	0.000899	CbGpPWpGaD
Carmustine—Hypersensitivity—Clonazepam—epilepsy syndrome	0.000111	0.000249	CcSEcCtD
Carmustine—Dizziness—Vigabatrin—epilepsy syndrome	0.000111	0.000248	CcSEcCtD
Carmustine—Confusional state—Valproic Acid—epilepsy syndrome	0.000111	0.000248	CcSEcCtD
Carmustine—Hypersensitivity—Phenytoin—epilepsy syndrome	0.00011	0.000247	CcSEcCtD
Carmustine—GSR—Metabolism—PLCB1—epilepsy syndrome	0.00011	0.00089	CbGpPWpGaD
Carmustine—GSR—Metabolism—TH—epilepsy syndrome	0.00011	0.000886	CbGpPWpGaD
Carmustine—Oedema—Valproic Acid—epilepsy syndrome	0.00011	0.000246	CcSEcCtD
Carmustine—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	0.00011	0.000246	CcSEcCtD
Carmustine—Nausea—Propofol—epilepsy syndrome	0.000109	0.000245	CcSEcCtD
Carmustine—Vomiting—Fosphenytoin—epilepsy syndrome	0.000109	0.000245	CcSEcCtD
Carmustine—Diarrhoea—Felbamate—epilepsy syndrome	0.000109	0.000245	CcSEcCtD
Carmustine—Body temperature increased—Lamotrigine—epilepsy syndrome	0.000109	0.000244	CcSEcCtD
Carmustine—Abdominal pain—Lamotrigine—epilepsy syndrome	0.000109	0.000244	CcSEcCtD
Carmustine—Dizziness—Diazepam—epilepsy syndrome	0.000109	0.000244	CcSEcCtD
Carmustine—Infection—Valproic Acid—epilepsy syndrome	0.000109	0.000244	CcSEcCtD
Carmustine—Leukopenia—Pregabalin—epilepsy syndrome	0.000109	0.000244	CcSEcCtD
Carmustine—Rash—Fosphenytoin—epilepsy syndrome	0.000108	0.000243	CcSEcCtD
Carmustine—Dermatitis—Fosphenytoin—epilepsy syndrome	0.000108	0.000242	CcSEcCtD
Carmustine—Haemoglobin—Topiramate—epilepsy syndrome	0.000108	0.000242	CcSEcCtD
Carmustine—Asthenia—Clonazepam—epilepsy syndrome	0.000108	0.000242	CcSEcCtD
Carmustine—Back pain—Gabapentin—epilepsy syndrome	0.000108	0.000241	CcSEcCtD
Carmustine—Headache—Fosphenytoin—epilepsy syndrome	0.000108	0.000241	CcSEcCtD
Carmustine—Haemorrhage—Topiramate—epilepsy syndrome	0.000108	0.000241	CcSEcCtD
Carmustine—Thrombocytopenia—Valproic Acid—epilepsy syndrome	0.000107	0.00024	CcSEcCtD
Carmustine—Asthenia—Phenytoin—epilepsy syndrome	0.000107	0.00024	CcSEcCtD
Carmustine—Nausea—Midazolam—epilepsy syndrome	0.000107	0.00024	CcSEcCtD
Carmustine—Hallucination—Topiramate—epilepsy syndrome	0.000107	0.00024	CcSEcCtD
Carmustine—Hypoaesthesia—Topiramate—epilepsy syndrome	0.000107	0.00024	CcSEcCtD
Carmustine—Tachycardia—Valproic Acid—epilepsy syndrome	0.000107	0.00024	CcSEcCtD
Carmustine—Diarrhoea—Zonisamide—epilepsy syndrome	0.000107	0.000239	CcSEcCtD
Carmustine—Asthenia—Oxcarbazepine—epilepsy syndrome	0.000107	0.000239	CcSEcCtD
Carmustine—Vomiting—Vigabatrin—epilepsy syndrome	0.000107	0.000239	CcSEcCtD
Carmustine—Oedema peripheral—Topiramate—epilepsy syndrome	0.000106	0.000238	CcSEcCtD
Carmustine—Connective tissue disorder—Topiramate—epilepsy syndrome	0.000106	0.000237	CcSEcCtD
Carmustine—Nausea—Levetiracetam—epilepsy syndrome	0.000106	0.000237	CcSEcCtD
Carmustine—Rash—Vigabatrin—epilepsy syndrome	0.000106	0.000237	CcSEcCtD
Carmustine—Dizziness—Felbamate—epilepsy syndrome	0.000106	0.000236	CcSEcCtD
Carmustine—Dermatitis—Vigabatrin—epilepsy syndrome	0.000106	0.000236	CcSEcCtD
Carmustine—Convulsion—Pregabalin—epilepsy syndrome	0.000105	0.000236	CcSEcCtD
Carmustine—Hypersensitivity—Carbamazepine—epilepsy syndrome	0.000105	0.000236	CcSEcCtD
Carmustine—Vision blurred—Gabapentin—epilepsy syndrome	0.000105	0.000235	CcSEcCtD
Carmustine—Headache—Vigabatrin—epilepsy syndrome	0.000105	0.000235	CcSEcCtD
Carmustine—Hypertension—Pregabalin—epilepsy syndrome	0.000105	0.000235	CcSEcCtD
Carmustine—Vomiting—Diazepam—epilepsy syndrome	0.000105	0.000235	CcSEcCtD
Carmustine—Anorexia—Valproic Acid—epilepsy syndrome	0.000105	0.000234	CcSEcCtD
Carmustine—Tremor—Gabapentin—epilepsy syndrome	0.000104	0.000234	CcSEcCtD
Carmustine—Rash—Diazepam—epilepsy syndrome	0.000104	0.000233	CcSEcCtD
Carmustine—Dermatitis—Diazepam—epilepsy syndrome	0.000104	0.000233	CcSEcCtD
Carmustine—Visual impairment—Topiramate—epilepsy syndrome	0.000104	0.000232	CcSEcCtD
Carmustine—Myalgia—Pregabalin—epilepsy syndrome	0.000103	0.000232	CcSEcCtD
Carmustine—Chest pain—Pregabalin—epilepsy syndrome	0.000103	0.000232	CcSEcCtD
Carmustine—Dizziness—Zonisamide—epilepsy syndrome	0.000103	0.000231	CcSEcCtD
Carmustine—Headache—Diazepam—epilepsy syndrome	0.000103	0.000231	CcSEcCtD
Carmustine—Anxiety—Pregabalin—epilepsy syndrome	0.000103	0.000231	CcSEcCtD
Carmustine—Diarrhoea—Clonazepam—epilepsy syndrome	0.000103	0.000231	CcSEcCtD
Carmustine—Anaemia—Gabapentin—epilepsy syndrome	0.000103	0.000231	CcSEcCtD
Carmustine—Hypotension—Valproic Acid—epilepsy syndrome	0.000102	0.000229	CcSEcCtD
Carmustine—Asthenia—Carbamazepine—epilepsy syndrome	0.000102	0.000229	CcSEcCtD
Carmustine—Agitation—Gabapentin—epilepsy syndrome	0.000102	0.000229	CcSEcCtD
Carmustine—Diarrhoea—Phenytoin—epilepsy syndrome	0.000102	0.000229	CcSEcCtD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—RELA—epilepsy syndrome	0.000102	0.000827	CbGpPWpGaD
Carmustine—Nausea—Fosphenytoin—epilepsy syndrome	0.000102	0.000229	CcSEcCtD
Carmustine—Diarrhoea—Oxcarbazepine—epilepsy syndrome	0.000102	0.000228	CcSEcCtD
Carmustine—Hypersensitivity—Lamotrigine—epilepsy syndrome	0.000102	0.000228	CcSEcCtD
Carmustine—Vomiting—Felbamate—epilepsy syndrome	0.000101	0.000227	CcSEcCtD
Carmustine—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—epilepsy syndrome	0.000101	0.000814	CbGpPWpGaD
Carmustine—Rash—Felbamate—epilepsy syndrome	0.000101	0.000225	CcSEcCtD
Carmustine—Eye disorder—Topiramate—epilepsy syndrome	0.000101	0.000225	CcSEcCtD
Carmustine—Dermatitis—Felbamate—epilepsy syndrome	0.000101	0.000225	CcSEcCtD
Carmustine—Headache—Felbamate—epilepsy syndrome	0.0001	0.000224	CcSEcCtD
Carmustine—Confusional state—Pregabalin—epilepsy syndrome	0.0001	0.000224	CcSEcCtD
Carmustine—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	9.99e-05	0.000224	CcSEcCtD
Carmustine—Flushing—Topiramate—epilepsy syndrome	9.99e-05	0.000224	CcSEcCtD
Carmustine—Leukopenia—Gabapentin—epilepsy syndrome	9.97e-05	0.000223	CcSEcCtD
Carmustine—Dizziness—Clonazepam—epilepsy syndrome	9.96e-05	0.000223	CcSEcCtD
Carmustine—Nausea—Vigabatrin—epilepsy syndrome	9.95e-05	0.000223	CcSEcCtD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—epilepsy syndrome	9.94e-05	0.000803	CbGpPWpGaD
Carmustine—Vomiting—Zonisamide—epilepsy syndrome	9.93e-05	0.000223	CcSEcCtD
Carmustine—Insomnia—Valproic Acid—epilepsy syndrome	9.92e-05	0.000222	CcSEcCtD
Carmustine—Oedema—Pregabalin—epilepsy syndrome	9.91e-05	0.000222	CcSEcCtD
Carmustine—Asthenia—Lamotrigine—epilepsy syndrome	9.9e-05	0.000222	CcSEcCtD
Carmustine—Dizziness—Phenytoin—epilepsy syndrome	9.89e-05	0.000222	CcSEcCtD
Carmustine—CYP1A2—Biological oxidations—CYP2C19—epilepsy syndrome	9.88e-05	0.000798	CbGpPWpGaD
Carmustine—Rash—Zonisamide—epilepsy syndrome	9.85e-05	0.000221	CcSEcCtD
Carmustine—Infection—Pregabalin—epilepsy syndrome	9.85e-05	0.000221	CcSEcCtD
Carmustine—Paraesthesia—Valproic Acid—epilepsy syndrome	9.85e-05	0.000221	CcSEcCtD
Carmustine—Dermatitis—Zonisamide—epilepsy syndrome	9.84e-05	0.00022	CcSEcCtD
Carmustine—Dizziness—Oxcarbazepine—epilepsy syndrome	9.84e-05	0.00022	CcSEcCtD
Carmustine—CYP1A2—Biological oxidations—CYP11A1—epilepsy syndrome	9.82e-05	0.000793	CbGpPWpGaD
Carmustine—Nausea—Diazepam—epilepsy syndrome	9.8e-05	0.000219	CcSEcCtD
Carmustine—Headache—Zonisamide—epilepsy syndrome	9.79e-05	0.000219	CcSEcCtD
Carmustine—Dyspnoea—Valproic Acid—epilepsy syndrome	9.78e-05	0.000219	CcSEcCtD
Carmustine—Diarrhoea—Carbamazepine—epilepsy syndrome	9.77e-05	0.000219	CcSEcCtD
Carmustine—Somnolence—Valproic Acid—epilepsy syndrome	9.75e-05	0.000218	CcSEcCtD
Carmustine—CYP1A2—Metapathway biotransformation—CYP2C19—epilepsy syndrome	9.74e-05	0.000787	CbGpPWpGaD
Carmustine—Thrombocytopenia—Pregabalin—epilepsy syndrome	9.71e-05	0.000217	CcSEcCtD
Carmustine—CYP1A2—Metapathway biotransformation—CYP11A1—epilepsy syndrome	9.68e-05	0.000782	CbGpPWpGaD
Carmustine—Tachycardia—Pregabalin—epilepsy syndrome	9.68e-05	0.000217	CcSEcCtD
Carmustine—Convulsion—Gabapentin—epilepsy syndrome	9.65e-05	0.000216	CcSEcCtD
Carmustine—Hypertension—Gabapentin—epilepsy syndrome	9.62e-05	0.000215	CcSEcCtD
Carmustine—Vomiting—Clonazepam—epilepsy syndrome	9.57e-05	0.000214	CcSEcCtD
Carmustine—Decreased appetite—Valproic Acid—epilepsy syndrome	9.53e-05	0.000214	CcSEcCtD
Carmustine—Alopecia—Topiramate—epilepsy syndrome	9.51e-05	0.000213	CcSEcCtD
Carmustine—Vomiting—Phenytoin—epilepsy syndrome	9.51e-05	0.000213	CcSEcCtD
Carmustine—Rash—Clonazepam—epilepsy syndrome	9.5e-05	0.000213	CcSEcCtD
Carmustine—Dermatitis—Clonazepam—epilepsy syndrome	9.49e-05	0.000212	CcSEcCtD
Carmustine—Myalgia—Gabapentin—epilepsy syndrome	9.48e-05	0.000212	CcSEcCtD
Carmustine—Chest pain—Gabapentin—epilepsy syndrome	9.48e-05	0.000212	CcSEcCtD
Carmustine—Nausea—Felbamate—epilepsy syndrome	9.48e-05	0.000212	CcSEcCtD
Carmustine—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	9.47e-05	0.000212	CcSEcCtD
Carmustine—Vomiting—Oxcarbazepine—epilepsy syndrome	9.46e-05	0.000212	CcSEcCtD
Carmustine—Anxiety—Gabapentin—epilepsy syndrome	9.45e-05	0.000212	CcSEcCtD
Carmustine—Anorexia—Pregabalin—epilepsy syndrome	9.45e-05	0.000212	CcSEcCtD
Carmustine—Dizziness—Carbamazepine—epilepsy syndrome	9.44e-05	0.000211	CcSEcCtD
Carmustine—Diarrhoea—Lamotrigine—epilepsy syndrome	9.44e-05	0.000211	CcSEcCtD
Carmustine—Headache—Clonazepam—epilepsy syndrome	9.43e-05	0.000211	CcSEcCtD
Carmustine—Rash—Phenytoin—epilepsy syndrome	9.43e-05	0.000211	CcSEcCtD
Carmustine—Mental disorder—Topiramate—epilepsy syndrome	9.43e-05	0.000211	CcSEcCtD
Carmustine—Dermatitis—Phenytoin—epilepsy syndrome	9.42e-05	0.000211	CcSEcCtD
Carmustine—Rash—Oxcarbazepine—epilepsy syndrome	9.38e-05	0.00021	CcSEcCtD
Carmustine—Pain—Valproic Acid—epilepsy syndrome	9.38e-05	0.00021	CcSEcCtD
Carmustine—Constipation—Valproic Acid—epilepsy syndrome	9.38e-05	0.00021	CcSEcCtD
Carmustine—Dermatitis—Oxcarbazepine—epilepsy syndrome	9.37e-05	0.00021	CcSEcCtD
Carmustine—Headache—Phenytoin—epilepsy syndrome	9.37e-05	0.00021	CcSEcCtD
Carmustine—Malnutrition—Topiramate—epilepsy syndrome	9.37e-05	0.00021	CcSEcCtD
Carmustine—Erythema—Topiramate—epilepsy syndrome	9.37e-05	0.00021	CcSEcCtD
Carmustine—Headache—Oxcarbazepine—epilepsy syndrome	9.32e-05	0.000209	CcSEcCtD
Carmustine—CYP1A2—Arachidonic acid metabolism—PTGS2—epilepsy syndrome	9.3e-05	0.000751	CbGpPWpGaD
Carmustine—Nausea—Zonisamide—epilepsy syndrome	9.28e-05	0.000208	CcSEcCtD
Carmustine—Hypotension—Pregabalin—epilepsy syndrome	9.26e-05	0.000207	CcSEcCtD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—epilepsy syndrome	9.25e-05	0.000747	CbGpPWpGaD
Carmustine—Confusional state—Gabapentin—epilepsy syndrome	9.17e-05	0.000205	CcSEcCtD
Carmustine—GSR—Metabolism—HMOX1—epilepsy syndrome	9.16e-05	0.00074	CbGpPWpGaD
Carmustine—Dizziness—Lamotrigine—epilepsy syndrome	9.13e-05	0.000204	CcSEcCtD
Carmustine—Oedema—Gabapentin—epilepsy syndrome	9.09e-05	0.000204	CcSEcCtD
Carmustine—Vomiting—Carbamazepine—epilepsy syndrome	9.08e-05	0.000203	CcSEcCtD
Carmustine—Back pain—Topiramate—epilepsy syndrome	9.06e-05	0.000203	CcSEcCtD
Carmustine—Feeling abnormal—Valproic Acid—epilepsy syndrome	9.04e-05	0.000202	CcSEcCtD
Carmustine—GSR—Metabolism—CAT—epilepsy syndrome	9.03e-05	0.00073	CbGpPWpGaD
Carmustine—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	9.03e-05	0.000202	CcSEcCtD
Carmustine—Infection—Gabapentin—epilepsy syndrome	9.03e-05	0.000202	CcSEcCtD
Carmustine—Rash—Carbamazepine—epilepsy syndrome	9e-05	0.000202	CcSEcCtD
Carmustine—Dermatitis—Carbamazepine—epilepsy syndrome	8.99e-05	0.000201	CcSEcCtD
Carmustine—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	8.97e-05	0.000201	CcSEcCtD
Carmustine—Insomnia—Pregabalin—epilepsy syndrome	8.97e-05	0.000201	CcSEcCtD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—epilepsy syndrome	8.96e-05	0.000724	CbGpPWpGaD
Carmustine—Nausea—Clonazepam—epilepsy syndrome	8.94e-05	0.0002	CcSEcCtD
Carmustine—Headache—Carbamazepine—epilepsy syndrome	8.94e-05	0.0002	CcSEcCtD
Carmustine—Paraesthesia—Pregabalin—epilepsy syndrome	8.9e-05	0.000199	CcSEcCtD
Carmustine—Thrombocytopenia—Gabapentin—epilepsy syndrome	8.9e-05	0.000199	CcSEcCtD
Carmustine—Nausea—Phenytoin—epilepsy syndrome	8.89e-05	0.000199	CcSEcCtD
Carmustine—Tachycardia—Gabapentin—epilepsy syndrome	8.87e-05	0.000199	CcSEcCtD
Carmustine—CYP1A2—Biological oxidations—CYP2D6—epilepsy syndrome	8.86e-05	0.000716	CbGpPWpGaD
Carmustine—Dyspnoea—Pregabalin—epilepsy syndrome	8.84e-05	0.000198	CcSEcCtD
Carmustine—Nausea—Oxcarbazepine—epilepsy syndrome	8.84e-05	0.000198	CcSEcCtD
Carmustine—Vision blurred—Topiramate—epilepsy syndrome	8.83e-05	0.000198	CcSEcCtD
Carmustine—Somnolence—Pregabalin—epilepsy syndrome	8.81e-05	0.000197	CcSEcCtD
Carmustine—GSR—Metabolism—ABCB1—epilepsy syndrome	8.79e-05	0.00071	CbGpPWpGaD
Carmustine—Tremor—Topiramate—epilepsy syndrome	8.78e-05	0.000197	CcSEcCtD
Carmustine—Vomiting—Lamotrigine—epilepsy syndrome	8.77e-05	0.000197	CcSEcCtD
Carmustine—CYP1A2—Metapathway biotransformation—CYP2D6—epilepsy syndrome	8.74e-05	0.000706	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—SLCO1A2—epilepsy syndrome	8.71e-05	0.000704	CbGpPWpGaD
Carmustine—Rash—Lamotrigine—epilepsy syndrome	8.7e-05	0.000195	CcSEcCtD
Carmustine—Dermatitis—Lamotrigine—epilepsy syndrome	8.69e-05	0.000195	CcSEcCtD
Carmustine—Body temperature increased—Valproic Acid—epilepsy syndrome	8.67e-05	0.000194	CcSEcCtD
Carmustine—Abdominal pain—Valproic Acid—epilepsy syndrome	8.67e-05	0.000194	CcSEcCtD
Carmustine—Anorexia—Gabapentin—epilepsy syndrome	8.67e-05	0.000194	CcSEcCtD
Carmustine—Anaemia—Topiramate—epilepsy syndrome	8.66e-05	0.000194	CcSEcCtD
Carmustine—Headache—Lamotrigine—epilepsy syndrome	8.64e-05	0.000194	CcSEcCtD
Carmustine—Decreased appetite—Pregabalin—epilepsy syndrome	8.62e-05	0.000193	CcSEcCtD
Carmustine—Agitation—Topiramate—epilepsy syndrome	8.61e-05	0.000193	CcSEcCtD
Carmustine—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	8.56e-05	0.000192	CcSEcCtD
Carmustine—Hypotension—Gabapentin—epilepsy syndrome	8.49e-05	0.00019	CcSEcCtD
Carmustine—Nausea—Carbamazepine—epilepsy syndrome	8.48e-05	0.00019	CcSEcCtD
Carmustine—Constipation—Pregabalin—epilepsy syndrome	8.48e-05	0.00019	CcSEcCtD
Carmustine—Pain—Pregabalin—epilepsy syndrome	8.48e-05	0.00019	CcSEcCtD
Carmustine—Leukopenia—Topiramate—epilepsy syndrome	8.39e-05	0.000188	CcSEcCtD
Carmustine—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	8.28e-05	0.000185	CcSEcCtD
Carmustine—Insomnia—Gabapentin—epilepsy syndrome	8.22e-05	0.000184	CcSEcCtD
Carmustine—Nausea—Lamotrigine—epilepsy syndrome	8.2e-05	0.000184	CcSEcCtD
Carmustine—GSR—Metabolism—GPX1—epilepsy syndrome	8.17e-05	0.00066	CbGpPWpGaD
Carmustine—CYP1A2—Phase 1 - Functionalization of compounds—POMC—epilepsy syndrome	8.17e-05	0.00066	CbGpPWpGaD
Carmustine—Feeling abnormal—Pregabalin—epilepsy syndrome	8.17e-05	0.000183	CcSEcCtD
Carmustine—Paraesthesia—Gabapentin—epilepsy syndrome	8.16e-05	0.000183	CcSEcCtD
Carmustine—Convulsion—Topiramate—epilepsy syndrome	8.12e-05	0.000182	CcSEcCtD
Carmustine—Gastrointestinal pain—Pregabalin—epilepsy syndrome	8.11e-05	0.000182	CcSEcCtD
Carmustine—Dyspnoea—Gabapentin—epilepsy syndrome	8.1e-05	0.000182	CcSEcCtD
Carmustine—Hypertension—Topiramate—epilepsy syndrome	8.09e-05	0.000181	CcSEcCtD
Carmustine—Somnolence—Gabapentin—epilepsy syndrome	8.08e-05	0.000181	CcSEcCtD
Carmustine—Hypersensitivity—Valproic Acid—epilepsy syndrome	8.08e-05	0.000181	CcSEcCtD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—SRC—epilepsy syndrome	8.04e-05	0.00065	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—epilepsy syndrome	8.04e-05	0.00065	CbGpPWpGaD
Carmustine—Chest pain—Topiramate—epilepsy syndrome	7.98e-05	0.000179	CcSEcCtD
Carmustine—Myalgia—Topiramate—epilepsy syndrome	7.98e-05	0.000179	CcSEcCtD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—NEU1—epilepsy syndrome	7.97e-05	0.000644	CbGpPWpGaD
Carmustine—Anxiety—Topiramate—epilepsy syndrome	7.95e-05	0.000178	CcSEcCtD
Carmustine—Decreased appetite—Gabapentin—epilepsy syndrome	7.9e-05	0.000177	CcSEcCtD
Carmustine—Asthenia—Valproic Acid—epilepsy syndrome	7.87e-05	0.000176	CcSEcCtD
Carmustine—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	7.85e-05	0.000176	CcSEcCtD
Carmustine—Abdominal pain—Pregabalin—epilepsy syndrome	7.84e-05	0.000176	CcSEcCtD
Carmustine—Body temperature increased—Pregabalin—epilepsy syndrome	7.84e-05	0.000176	CcSEcCtD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—epilepsy syndrome	7.83e-05	0.000633	CbGpPWpGaD
Carmustine—Constipation—Gabapentin—epilepsy syndrome	7.77e-05	0.000174	CcSEcCtD
Carmustine—Pain—Gabapentin—epilepsy syndrome	7.77e-05	0.000174	CcSEcCtD
Carmustine—Confusional state—Topiramate—epilepsy syndrome	7.71e-05	0.000173	CcSEcCtD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—HSD17B4—epilepsy syndrome	7.67e-05	0.00062	CbGpPWpGaD
Carmustine—Oedema—Topiramate—epilepsy syndrome	7.65e-05	0.000171	CcSEcCtD
Carmustine—Infection—Topiramate—epilepsy syndrome	7.6e-05	0.00017	CcSEcCtD
Carmustine—Diarrhoea—Valproic Acid—epilepsy syndrome	7.5e-05	0.000168	CcSEcCtD
Carmustine—Feeling abnormal—Gabapentin—epilepsy syndrome	7.49e-05	0.000168	CcSEcCtD
Carmustine—Thrombocytopenia—Topiramate—epilepsy syndrome	7.49e-05	0.000168	CcSEcCtD
Carmustine—Tachycardia—Topiramate—epilepsy syndrome	7.46e-05	0.000167	CcSEcCtD
Carmustine—Gastrointestinal pain—Gabapentin—epilepsy syndrome	7.43e-05	0.000166	CcSEcCtD
Carmustine—Hypersensitivity—Pregabalin—epilepsy syndrome	7.3e-05	0.000164	CcSEcCtD
Carmustine—Anorexia—Topiramate—epilepsy syndrome	7.29e-05	0.000163	CcSEcCtD
Carmustine—Dizziness—Valproic Acid—epilepsy syndrome	7.25e-05	0.000162	CcSEcCtD
Carmustine—Body temperature increased—Gabapentin—epilepsy syndrome	7.19e-05	0.000161	CcSEcCtD
Carmustine—Abdominal pain—Gabapentin—epilepsy syndrome	7.19e-05	0.000161	CcSEcCtD
Carmustine—GSR—Metabolism—AGT—epilepsy syndrome	7.16e-05	0.000579	CbGpPWpGaD
Carmustine—Hypotension—Topiramate—epilepsy syndrome	7.15e-05	0.00016	CcSEcCtD
Carmustine—Asthenia—Pregabalin—epilepsy syndrome	7.11e-05	0.000159	CcSEcCtD
Carmustine—GSR—Metabolism—APOE—epilepsy syndrome	7.02e-05	0.000567	CbGpPWpGaD
Carmustine—Vomiting—Valproic Acid—epilepsy syndrome	6.97e-05	0.000156	CcSEcCtD
Carmustine—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	6.97e-05	0.000156	CcSEcCtD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—ASAH1—epilepsy syndrome	6.97e-05	0.000563	CbGpPWpGaD
Carmustine—Insomnia—Topiramate—epilepsy syndrome	6.92e-05	0.000155	CcSEcCtD
Carmustine—Rash—Valproic Acid—epilepsy syndrome	6.91e-05	0.000155	CcSEcCtD
Carmustine—Dermatitis—Valproic Acid—epilepsy syndrome	6.91e-05	0.000155	CcSEcCtD
Carmustine—Headache—Valproic Acid—epilepsy syndrome	6.87e-05	0.000154	CcSEcCtD
Carmustine—Paraesthesia—Topiramate—epilepsy syndrome	6.87e-05	0.000154	CcSEcCtD
Carmustine—Dyspnoea—Topiramate—epilepsy syndrome	6.82e-05	0.000153	CcSEcCtD
Carmustine—Somnolence—Topiramate—epilepsy syndrome	6.8e-05	0.000152	CcSEcCtD
Carmustine—Diarrhoea—Pregabalin—epilepsy syndrome	6.78e-05	0.000152	CcSEcCtD
Carmustine—CYP1A2—Metabolism—CA13—epilepsy syndrome	6.76e-05	0.000546	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—epilepsy syndrome	6.71e-05	0.000542	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—epilepsy syndrome	6.71e-05	0.000542	CbGpPWpGaD
Carmustine—Hypersensitivity—Gabapentin—epilepsy syndrome	6.7e-05	0.00015	CcSEcCtD
Carmustine—Decreased appetite—Topiramate—epilepsy syndrome	6.65e-05	0.000149	CcSEcCtD
Carmustine—Gastrointestinal disorder—Topiramate—epilepsy syndrome	6.6e-05	0.000148	CcSEcCtD
Carmustine—Dizziness—Pregabalin—epilepsy syndrome	6.56e-05	0.000147	CcSEcCtD
Carmustine—Constipation—Topiramate—epilepsy syndrome	6.54e-05	0.000146	CcSEcCtD
Carmustine—Pain—Topiramate—epilepsy syndrome	6.54e-05	0.000146	CcSEcCtD
Carmustine—Asthenia—Gabapentin—epilepsy syndrome	6.52e-05	0.000146	CcSEcCtD
Carmustine—Nausea—Valproic Acid—epilepsy syndrome	6.51e-05	0.000146	CcSEcCtD
Carmustine—Vomiting—Pregabalin—epilepsy syndrome	6.3e-05	0.000141	CcSEcCtD
Carmustine—Feeling abnormal—Topiramate—epilepsy syndrome	6.3e-05	0.000141	CcSEcCtD
Carmustine—Gastrointestinal pain—Topiramate—epilepsy syndrome	6.25e-05	0.00014	CcSEcCtD
Carmustine—Rash—Pregabalin—epilepsy syndrome	6.25e-05	0.00014	CcSEcCtD
Carmustine—Dermatitis—Pregabalin—epilepsy syndrome	6.24e-05	0.00014	CcSEcCtD
Carmustine—Diarrhoea—Gabapentin—epilepsy syndrome	6.22e-05	0.000139	CcSEcCtD
Carmustine—Headache—Pregabalin—epilepsy syndrome	6.21e-05	0.000139	CcSEcCtD
Carmustine—Body temperature increased—Topiramate—epilepsy syndrome	6.05e-05	0.000135	CcSEcCtD
Carmustine—Abdominal pain—Topiramate—epilepsy syndrome	6.05e-05	0.000135	CcSEcCtD
Carmustine—GSR—Metabolism—POMC—epilepsy syndrome	6.03e-05	0.000487	CbGpPWpGaD
Carmustine—Dizziness—Gabapentin—epilepsy syndrome	6.01e-05	0.000135	CcSEcCtD
Carmustine—Nausea—Pregabalin—epilepsy syndrome	5.89e-05	0.000132	CcSEcCtD
Carmustine—Vomiting—Gabapentin—epilepsy syndrome	5.78e-05	0.000129	CcSEcCtD
Carmustine—Rash—Gabapentin—epilepsy syndrome	5.73e-05	0.000128	CcSEcCtD
Carmustine—Dermatitis—Gabapentin—epilepsy syndrome	5.73e-05	0.000128	CcSEcCtD
Carmustine—Headache—Gabapentin—epilepsy syndrome	5.69e-05	0.000128	CcSEcCtD
Carmustine—Hypersensitivity—Topiramate—epilepsy syndrome	5.63e-05	0.000126	CcSEcCtD
Carmustine—GSR—Metabolism—ALB—epilepsy syndrome	5.5e-05	0.000444	CbGpPWpGaD
Carmustine—Asthenia—Topiramate—epilepsy syndrome	5.49e-05	0.000123	CcSEcCtD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—TXNRD1—epilepsy syndrome	5.44e-05	0.000439	CbGpPWpGaD
Carmustine—Nausea—Gabapentin—epilepsy syndrome	5.4e-05	0.000121	CcSEcCtD
Carmustine—Diarrhoea—Topiramate—epilepsy syndrome	5.23e-05	0.000117	CcSEcCtD
Carmustine—CYP1A2—Metabolism—PDXK—epilepsy syndrome	5.12e-05	0.000414	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—CERS1—epilepsy syndrome	5.12e-05	0.000414	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—GLUD1—epilepsy syndrome	5.12e-05	0.000414	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—ADK—epilepsy syndrome	5.12e-05	0.000414	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—L2HGDH—epilepsy syndrome	5.12e-05	0.000414	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—FAR1—epilepsy syndrome	5.12e-05	0.000414	CbGpPWpGaD
Carmustine—Dizziness—Topiramate—epilepsy syndrome	5.06e-05	0.000113	CcSEcCtD
Carmustine—Vomiting—Topiramate—epilepsy syndrome	4.86e-05	0.000109	CcSEcCtD
Carmustine—Rash—Topiramate—epilepsy syndrome	4.82e-05	0.000108	CcSEcCtD
Carmustine—Dermatitis—Topiramate—epilepsy syndrome	4.82e-05	0.000108	CcSEcCtD
Carmustine—GSR—Metabolism—PTGS2—epilepsy syndrome	4.81e-05	0.000389	CbGpPWpGaD
Carmustine—Headache—Topiramate—epilepsy syndrome	4.79e-05	0.000107	CcSEcCtD
Carmustine—CYP1A2—Metabolism—PNPO—epilepsy syndrome	4.68e-05	0.000378	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—EPM2A—epilepsy syndrome	4.68e-05	0.000378	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—GAMT—epilepsy syndrome	4.68e-05	0.000378	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—NHLRC1—epilepsy syndrome	4.68e-05	0.000378	CbGpPWpGaD
Carmustine—Nausea—Topiramate—epilepsy syndrome	4.54e-05	0.000102	CcSEcCtD
Carmustine—CYP1A2—Metabolism—CA4—epilepsy syndrome	4.35e-05	0.000352	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—QDPR—epilepsy syndrome	4.35e-05	0.000352	CbGpPWpGaD
Carmustine—CYP1A2—Biological oxidations—POMC—epilepsy syndrome	4.34e-05	0.000351	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—COX3—epilepsy syndrome	4.09e-05	0.000331	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—KCNB1—epilepsy syndrome	3.88e-05	0.000313	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—CACNA2D2—epilepsy syndrome	3.88e-05	0.000313	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—PFKL—epilepsy syndrome	3.88e-05	0.000313	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—SLCO1A2—epilepsy syndrome	3.88e-05	0.000313	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—SLC6A8—epilepsy syndrome	3.88e-05	0.000313	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	3.79e-05	0.000306	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	3.77e-05	0.000304	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—ATIC—epilepsy syndrome	3.55e-05	0.000287	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—UPB1—epilepsy syndrome	3.55e-05	0.000287	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—NEU1—epilepsy syndrome	3.55e-05	0.000287	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—HSD17B4—epilepsy syndrome	3.42e-05	0.000276	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—GBE1—epilepsy syndrome	3.3e-05	0.000267	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—PPP1R3C—epilepsy syndrome	3.3e-05	0.000267	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	3.22e-05	0.000261	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—ASAH1—epilepsy syndrome	3.1e-05	0.000251	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—STXBP1—epilepsy syndrome	3.02e-05	0.000244	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—NT5E—epilepsy syndrome	2.94e-05	0.000238	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—ALAD—epilepsy syndrome	2.94e-05	0.000238	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—CACNA1A—epilepsy syndrome	2.81e-05	0.000227	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—ALDH7A1—epilepsy syndrome	2.81e-05	0.000227	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—ST3GAL3—epilepsy syndrome	2.75e-05	0.000222	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—ADSL—epilepsy syndrome	2.69e-05	0.000217	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—GLUL—epilepsy syndrome	2.64e-05	0.000213	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—CACNA1D—epilepsy syndrome	2.59e-05	0.000209	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—TXNRD1—epilepsy syndrome	2.42e-05	0.000196	CbGpPWpGaD
Carmustine—GSR—Metabolism—AKT1—epilepsy syndrome	2.42e-05	0.000195	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—AQP1—epilepsy syndrome	2.35e-05	0.00019	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	2.26e-05	0.000182	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—CHRM3—epilepsy syndrome	2.13e-05	0.000172	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—KCNJ11—epilepsy syndrome	2.13e-05	0.000172	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	1.98e-05	0.00016	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	1.94e-05	0.000157	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—ABCG2—epilepsy syndrome	1.73e-05	0.00014	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—CYP2C19—epilepsy syndrome	1.69e-05	0.000136	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—CYP11A1—epilepsy syndrome	1.68e-05	0.000136	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	1.67e-05	0.000135	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	1.52e-05	0.000123	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—CYP2D6—epilepsy syndrome	1.51e-05	0.000122	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—ADRA2A—epilepsy syndrome	1.44e-05	0.000117	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—BCHE—epilepsy syndrome	1.44e-05	0.000116	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—SLC2A1—epilepsy syndrome	1.37e-05	0.000111	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—PLCB1—epilepsy syndrome	1.36e-05	0.000109	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—TH—epilepsy syndrome	1.35e-05	0.000109	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.33e-05	0.000107	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—HMOX1—epilepsy syndrome	1.13e-05	9.1e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—CAT—epilepsy syndrome	1.11e-05	8.98e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—ABCB1—epilepsy syndrome	1.08e-05	8.74e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—GPX1—epilepsy syndrome	1.01e-05	8.12e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—AGT—epilepsy syndrome	8.82e-06	7.12e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—APOE—epilepsy syndrome	8.64e-06	6.98e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—POMC—epilepsy syndrome	7.42e-06	6e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—ALB—epilepsy syndrome	6.77e-06	5.47e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—PTGS2—epilepsy syndrome	5.92e-06	4.78e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—AKT1—epilepsy syndrome	2.98e-06	2.4e-05	CbGpPWpGaD
